Fig. 3
The number of latent variables (LVs) of the developed full spectrum (a) PCR and (b) PLS models for Safinamide mesylate (SAF), SAF impurity (4-HBD), SAF hydrolytic and oxidative degradation products.
Fig. 3 | Scientific Reports
The number of latent variables (LVs) of the developed full spectrum (a) PCR and (b) PLS models for Safinamide mesylate (SAF), SAF impurity (4-HBD), SAF hydrolytic and oxidative degradation products.
